BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16

• Press Releases

  AbCellera Appoints Dr. Lynn Seely to its Board of Directors

  July 6, 2026

   · 

  2 min read
• Press Releases

  Dr. Cherice Roth Named Chief Executive Officer of Purgo Scientific & Vetlen

  July 6, 2026

   · 

  4 min read
• Press Releases

  Orion and Shilpa Medicare Expand Partnership to Develop and Supply Nivolumab Biosimilar for Europe

  July 6, 2026

   · 

  2 min read
• 

  IPO

  Hair loss biotech Veradermics, up 656% since its IPO, credits the obesity boom

  After debuting on the public markets with $256.3 million and raking in an additional $472 million, Veradermics has emerged as one of biotech’s biggest post-IPO standouts. CEO Reid Waldman credits the weight loss craze for establishing consumer-driven channels.

  July 6, 2026

   · 

  5 min read

   · 

  Gabrielle Masson
• 

  Business

  Genentech culls 103 jobs, inks $490M-plus biobucks deal with Astex

  With the latest round, Roche’s Genentech will have racked up nearly 450 layoffs in California over the last year amid ongoing restructuring. At the same time, the biotech is joining forces with Astex Pharmaceuticals in a deal that could surpass $490 million.

  July 6, 2026

   · 

  2 min read

   · 

  Gabrielle Masson
• Press Releases

  Correction: Inspire Medical Systems, Inc. to Report Second Quarter 2026 Financial Results on August 3, 2026

  July 6, 2026

   · 

  1 min read
• Press Releases

  MESA LABS DECLARES QUARTERLY DIVIDEND - July 6, 2026

  July 6, 2026

   · 

  2 min read
• Press Releases

  Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules

  July 6, 2026

   · 

  5 min read
• Press Releases

  Curis Consents First Six Patients in TakeAim CLL Study

  July 6, 2026

   · 

  7 min read
• Press Releases

  Pulmongene Appoints Hunter C. Gillies, M.B.Ch.B, as Chief Medical Officer to Lead Global Clinical Development in Fibrotic and Pulmonary Diseases

  — Veteran Physician-Scientist Brings Over 25 Years of Pulmonary and Cardiopulmonary Clinical Development Leadership Spanning Pfizer, Gilead, and Aerovate Therapeutics —

  July 6, 2026

   · 

  1 min read